Redox-triggered contents release from liposomes

Journal of the American Chemical Society

Volumn 130, Issue 44, 2008, Pages 14739-14744

  Ong, Winston ^a   Yang, Yuming ^a   Cruciano, Angela C ^b   McCarley, Robin L ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; AMPHIPHILES; ENZYME ACTIVITY; ENZYMES; HISTOLOGY; LIPIDS; PHOSPHOLIPIDS;

CLEAVAGE EVENTS; ELECTRON REDUCTIONS; FLUORESCENT DYES; INFLAMMATORY DISEASES; KEY COMPONENTS; LIPOSOMAL DELIVERY SYSTEMS; NEW CLASSES; PHOSPHATIDYLETHANOL AMINES; QUINONE REDUCTASES; REDOX ACTIVATIONS; REDOX SWITCHES;

LIPOSOMES;

DIOLEOYL PHOSPHATIDYLETHANOLAMINE; LIPOSOME; QUINONE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; DRUG DELIVERY SYSTEM; ENZYME ACTIVATION; OXIDATION REDUCTION REACTION;

DRUG CARRIERS; FLUORESCEINS; FLUORESCENT DYES; LIPOSOMES; OXIDATION-REDUCTION; PHOSPHATIDYLETHANOLAMINES; QUINONES;

EID: 55549102682     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja8050469     Document Type: Article

References (69)

1. Savariar, E. N.; Ghosh, S.; Gonzalez, D. C.; Thayumanavan, S. J. Am. Chem. Soc. 2008, 130, 5416-5417.
2. Liu, J. W.; Lu, Y. J. Am. Chem. Soc. 2007, 129, 8634-8643.
3. Nijhuis, C. A.; Ravoo, B. J.; Huskens, J.; Reinhoudt, D. N. Coord. Chem. Rev. 2007, 251, 1761-1780.
4. Bellomo, E. G.; Wyrsta, M. D.; Pakstis, L.; Pochan, D. J.; Deming, T. J. Nat. Mater. 2004, 3, 244-248.
5. Dillenback, L. M.; Goodrich, G. P.; Keating, C. D. Nano Lett. 2006, 6, 16-23.
6. Wang, W.; Kaifer, A. E. Angew. Chem., Int. Ed. 2006, 45, 7042-7046.
7. Serizawa, T.; Yamaguchi, M.; Akashi, M. Angew. Chem., Int. Ed. 2003, 42, 1115-1118.
8. Whitaker-Brothers, K.; Uhrich, K. J. Biomed. Mater. Res., Part A 2004, 70A, 309-318.
9. Gugliotti, L. A.; Feldheim, D. L.; Eaton, B. E. J. Am. Chem. Soc. 2005, 127, 17814-17818.
10. Eastoe, J.; Vesperinas, A. Soft Matter 2005, 1, 338-347.
11. Goodwin, A. P.; Mynar, J. L.; Ma, Y. Z.; Fleming, G. R.; Frechet, J. M. J. J. Am. Chem. Soc. 2005, 127, 9952-9953.
12. Jiang, J. Q.; Tong, X.; Zhao, Y. J. Am. Chem. Soc. 2005, 127, 8290-8291.
13. Menger, F. M.; Gabrielson, K. J. Am. Chem. Soc. 1994, 116, 1567-1568.
14. Rui, Y. J.; Wang, S.; Low, P. S.; Thompson, D. H. J. Am. Chem. Soc. 1998, 120, 11213-11218.
15. Van Horn, B. A.; Wooley, K. L. Macromolecules 2007, 40, 1480-1488.
16. Allen, T. M.; Cullis, P. R. Science 2004, 303, 1818-1822.
17. Dreher, M. R.; Chilkoti, A. J. Natl. Cancer Inst. 2007, 99, 983-985.
18. Szalai, M. L.; Kevwitch, R. M.; McGrath, D. V. J. Am. Chem. Soc. 2003, 125, 15688-15689.
19. de Groot, F. M. H.; Albrecht, C.; Koekkoek, R.; Beusker, P. H.; Scheeren, H. W. Angew. Chem., Int. Ed. 2003, 42, 4490-4494.
20. Amir, R. J.; Shabat, D. In Polymer Therapeutics I: Polymers as Drugs, Conjugates and Gene Delivery Systems; Springer-Verlag Berlin: Berlin, 2006; Vol. 192, pp 59-94.
21. Sagi, A.; Weinstain, R.; Karton, N.; Shabat, D. J. Am. Chem. Soc. 2008, 130, 5434-ff.
22. Guo, X.; Szoka, F. C. Acc. Chem. Res. 2003, 36, 335-341.
23. Sawant, R. M.; Hurley, J. P.; Salmaso, S.; Kale, A.; Tolcheva, E.; Levchenko, T. S.; Torchilin, V. P. Bioconjugate Chem. 2006, 17, 943-949.
24. Andresen, T. L.; Jensen, S. S.; Kaasgaard, T.; Jorgensen, K. Curr. Drug Delivery 2005, 2, 353-362.
25. Fattal, E.; Couvreur, P.; Dubernet, C. Adv. Drug Delivery Rev. 2004, 56, 931-946.
26. Gerasimov, O. V.; Boomer, J. A.; Qualls, M. M.; Thompson, D. H. Adv. Drug Delivery Rev. 1999, 38, 317-338.
27. Zhang, J. X.; Zalipsky, S.; Mullah, N.; Pechar, M.; Allen, T. M. Pharmacol. Res. 2004, 49, 185-198.
28. Davidsen, J.; Jorgensen, K.; Andresen, T. L.; Mouritsen, O. G. Biochim. Biophys. Acta 2003, 1609, 95-101.
29. Meers, P. Adv. Drug Delivery Rev. 2001, 53, 265-272.
30. Huang, Z.; Szoka, F. C. In Liposome Technology, 3rd ed.; Gregoriadis, G., Ed.; CRC Press: Boca Raton, FL, 2006; Vol. 3, pp 165-196.
31. Sarkar, N.; Banerjee, J.; Hanson, A. J.; Elegbede, A. I.; Rosendahl, T.; Krueger, A. B.; Banerjee, A. L.; Tobwala, S.; Wang, R. Y.; Lu, X. N.; Mallik, S.; Srivastava, D. K. Bioconjugate Chem. 2008, 19, 57-64.
32. Kirpotin, D.; Hong, K. L.; Mullah, N.; Papahadjopoulos, D.; Zalipsky, S. FEBS Lett. 1996, 388, 115-118.
33. Tang, F. X.; Hughes, J. A. Biochem. Biophys. Res. Commun. 1998, 242, 141-145.
34. Zalipsky, S.; Qazen, M.; Walker, J. A.; Mullah, N.; Quinn, Y. P.; Huang, S. K. Bioconjugate Chem. 1999, 10, 703-707.
35. Chandra, B.; Mallik, S.; Srivastava, D. K. Chem. Commun. 2005, 3021-3023.
36. Eastoe, J.; Vesperinas, A.; Donnewirth, A. C.; Wyatt, P.; Grillo, I.; Heenan, R. K.; Davis, S. Langmuir 2006, 22, 851-853.
37. Shum, P.; Kim, J. M.; Thompson, D. H. Adv. Drug Delivery Rev. 2001, 53, 273-284.
38. Zhang, Z. Y.; Smith, B. D. Bioconjugate Chem. 1999, 10, 1150-1152.
39. Kono, K.; Murakami, T.; Yoshida, T.; Haba, Y.; Kanaoka, S.; Takagishi, T.; Aoshima, S. Bioconjugate Chem. 2005, 16, 1367-1374.
40. Needham, D.; Dewhirst, M. W. Adv. Drug Delivery Rev. 2001, 53, 285-305.
41. Boomer, J. A.; Inerowicz, H. D.; Zhang, Z. Y.; Bergstrand, N.; Edwards, K.; Kim, J. M.; Thompson, D. H. Langmuir 2003, 19, 6408-6415.
42. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. J. Controlled Release 2000, 65, 271-284.
43. Fitzsimmons, S. A.; Workman, P.; Grever, M.; Pauli, K.; Camalier, R.; Lewis, A. D. J. Natl. Cancer Inst. 1996, 88, 259-269.
44. Jaffar, M.; Abou-Zeid, N.; Bai, L.; Mrema, I.; Robinson, I.; Tanner, R.; Stafford, I. J. Curr. Drug Delivery 2004, 1, 345-350.
45. Weerapreeyakul, N.; Visser, P.; Brummelhuis, M.; Gharat, L.; Chikhale, P. J. Med. Chem. Res. 2000, 10, 149-163.
46. Lim, H. J.; Masin, D.; Madden, T. D.; Bally, M. B. J. Pharmacol. Exp. Ther. 1997, 281, 566-573.
47. Ponce, A. M.; Wright, A.; Dewhirst, M. W.; Needham, D. Future Lipidol. 2006, 1, 25-34.
48. The following nomenclature will be adapted throughout the article: "Q" and "HQ" refer to the oxidized and reduced forms of the quinone, respectively, regardless of whether "HQ" is generated in situ (e.g., 1-HQ3) or synthesized (e.g., 3-HQ1). For instance, 1-HQ1 is the reduced form of 1-Q1.
49. Carpino, L. A.; Triolo, S. A.; Berglund, R. A. J. Org. Chem. 1989, 54, 3303-3310.
50. Szoka, F.; Papahadjopoulos, D. Annu. Rev. Biophys. Bioeng. 1980, 9, 467-508.
51. Ong, W.; McCarley, R. L. Chem. Commun. 2005, 4699-4701.
52. Ong, W.; McCarley, R. L. Macromolecules 2006, 39, 7295-7301.
53. Yan, C.; Matsuda, W.; Pepperberg, D. R.; Zimmerman, S. C.; Leckband, D. E. J. Colloid Interface Sci. 2006, 296, 165-177.
54. Zheng, A.; Shan, D.; Wang, B. J. Org. Chem. 1999, 64, 156-161.
55. Siegel, D. P.; Epand, R. M. Biophys. J. 1997, 73, 3089-3111.
56. Milstien, S.; Cohen, L. A. J. Am. Chem. Soc. 1972, 94, 9158-9165.
57. Abbott, N. L.; Jewell, C. M.; Hays, M. E.; Kondo, Y.; Lynn, D. M. J. Am. Chem. Soc. 2005, 127, 11576-11577.
58. Kakizawa, Y.; Sakai, H.; Yamaguchi, A.; Kondo, Y.; Yoshino, N.; Abe, M. Langmuir 2001, 17, 8044-8048.
59. Munoz, S.; Gokel, G. W. J. Am. Chem. Soc. 1993, 115, 4899-4900.
60. Saji, T.; Hoshino, K.; Aoyagui, S. J. Am. Chem. Soc. 1985, 107, 6865-6868.
61. Calcein is known to be quenched by Triton, and this quenching is Triton concentration dependent. See: Memoli, A.; Palermiti, L. G.; Travagli, V.; Alhaique, F. J. Pharm. Biomed. Anal. 1999, 19, 627-632, and references therein for more information on this topic.
62. 0 is the initial emission intensity.
63. It is assumed here that the quinone units located in the outer layer of the liposomes are kinetically and equally accessible, such that probability of reduction of the liposomal lipids (1-Q1 and 1-Q3) can be approximated by the thermodynamic reduction potentials of the model quinones (2-Q1 and 2-Q3).
64. 4 is non-membrane-permeable and is therefore incapable of reducing the lipids located in the interior layer of the liposome. For instance, see: Angeletti, C.; Nichols, J. W. Biochemistry 1998, 37, 15114-15119.
65. Bentz, J.; Ellens, H.; Szoka, F. C. Biochemistry 1987, 26, 2105-2116.
66. Intraliposomal bilayer-bilayer contact in oligolamellar Q-DOPE liposomes may also contribute to liposome collapse and contents release. The mechanism of Q-DOPE liposome collapse is currently being investigated in detail.
67. Ellens, H.; Bentz, J.; Szoka, F. C. Biochemistry 1984, 23, 1532-1538.
68. Ross, D. Drug Metab. Rev. 2004, 36, 639-654.
69. Bahr, J. L.; Yang, J. P.; Kosynkin, D. V.; Bronikowski, M. J.; Smalley, R. E.; Tour, J. M. J. Am. Chem. Soc. 2001, 123, 6536-6542.